Synthetic peptide and its uses

Details Synthetic peptide and its uses Synthetic peptide and its uses

1996-04-05

1999-08-03

Spiegel, Carol A.

Chemistry: analytical and immunological testing

For preexisting immune complex or auto-immune disease

Immune complex

435 11, 4241851, 4241901, 514 2, 530300, 530326, 530327, 5303879, G01N 33564

Patent

active

059324830

ABSTRACT:
The invention provides a fragment of C1q which is characterized in that a plurality of such fragments selectively binds immune complexes or aggregated immunoglobulins in the presence of monomeric immunoglobulin. The invention also provides a synthetic peptide comprising the sequence:

REFERENCES:
patent: 3941763 (1976-03-01), Sarantakis
patent: 4546082 (1985-10-01), Kurjan et al.
patent: 4588684 (1986-05-01), Brake .
patent: 4775622 (1988-10-01), Hitzeman et al.
patent: 5084398 (1992-01-01), Huston et al.
patent: 5364930 (1994-11-01), Baumann et al.
Marques et al., "Arginine Residues of the Globular Regions of Human C1q Involved in the Interaction with Immunoglobulin G.," J. Biol. Chem, 268(14):10393-10402 May 15, 1993.
Henry.(ed), Clinical Diagnosis and Management by Laboratory Method Published 16.sup.th ed by W.B. Saunders pp. 1425-1429, 1979.
Ono et al., "Improved Technique of Heart Transplantation in Rats," J. of Thor. Cardiovas. Surg., 57: 225-229, 1969.
Romanella et al., "Involvement of Both the Classical and Alternate Pathways . . . in . . . Xenograft Rejection," Transplantation 63(7)1021-1025, 1997.
Schaff et al., "Simplified Method of Heterotopic Cardiac Transplantation . . . ," J. of Thor. Cardiovas. Surg. 85:434-439, 1983.
Deisenhofer et al, (1978), Hoppe-Seyler s Z. Physiol. Chem., 359:975-985.
Fryer, et al., "Inhibition Of Porcine Endothelial Cell Lysis By Human Serum Using Peptides Which Inhibit C1Q Deposition," XVI International Congress Of The Transplantation Society, Book of Abstracts, p. 83 (1996). Aug. 25-30.
Fryer, et al., "Inhibition Of Porcine Endothelial Cell Lysis By Human Serum Using Peptides Which Inhibit C1Q Deposition," American Society of Transplant Surgeons, 22nd Annual Scientific Meeting, p. 129 (1996). May 29-31.
Fryer, et al., "Inhibition Of Porcine Endothelial Cell Lysis By Human Serum Using Peptides Which Inhibit C1Q Deposition," International Business Communications, IBC's Second Bi-Annual Symposium On Zeno Transplantation, (no page No. given) (1996) Oct. 1-2.
Blair, A.H., and Ghose, T.I., J. Immunol. Methods, 59:129-143 (1983).
Burton, Molec. Immunol., 22, 161-206 (1985).
Burton, Molec. Immunol., 25, 1175-81 (1988).
Burton et al., Nature, 288, 388-44 (1980).
Chou and Fasman, Adv. Enzym., 47, 45-148 (1978).
Davis et al., Biochem. Int'l., 10, 395-404 (1985).
DeGrado et al., J. Am. Chem. Soc., 103, 679-81 (1981).
Duncan and Winter, Nature, 332, 738-40 (1988).
Ellman, Arch. Biochem. Biophys., 74, 443-450 (1958).
Ellman, Arch. Biochem. Biophys., 82, 70-77 (1959).
Fields, Meth. Enzymol., 25B, 464-68 (1972).
Garnier et al., J. Molec. Biol., 120, 97-120 (1978).
Gauthier et al., J. Exp. Med., 156:776-77 (1982).
Geusdon et al., J. Histochem. Cytochem., 27, 1131-39 (1979).
Hughes-Jones and Gardner, Immunology, 34, 459-63 (1978).
Jones et al., J. Immunol. Meth., 53, 201-208 (1982).
Kulkarni, P.N., Blair, A.H., and Ghose, T.I., Cancer Res., 41:2700-06 (1981).
Lancet et al., Biochem. Biophys. Res. Commun., 85, 608-614 (1978).
Langone et al., Adv. Immunol., 32, 157-252 (1982).
Langone et al., J. Immunol., 121, 327-32 (1978).
Lukas et al., J. Immunol., 127, 2555-60 (1981).
Marquart et al., J. Mol. Biol., 141, 369-91 (1980).
Merrifield, J. Am. Chem. Soc., 85, 2149-54 (1963).
Moe and Kaiser, Biochem., 24, 1971-76 (1985).
Prystowsky et al., Biochemistry, 20, 6349-56 (1981).
Reid, Biochemical J., 179, 367-71 (1979).
Reid et al., Biochemical J., 203, 559-69 (1982).
Stalinheim et al., Immunochem., 10, 501-507 (1973).
Taylor et al., Mol. Pharmacol., 22, 657-66 (1982).
Theofilopoulos and Dixon, Adv. Immunol., 28, 89-220 (1979).
Baumann and Anderson, J. Biol. Chem., 265, 18414-18422 (Oct. 25, 1990).
Veerhuis et al., Eur. J. Immunol., 15, 881-887 (1985).
Bach, et al., "Barriers to xenotransplantation," Nature Medicine, vol. 1, No. 9, pp. 869-873 (1995).
Baldwin, et al., "Complement in Organ Transplantation," Transplantation, vol. 59, No. 6, pp. 797-808 (1995).
Cozzi, et al., "The generation of transgenic pigs as potential organ donors for humans," Nature Medicine, vol. 1, No. 9, pp. 964-966 (1995).
Deisenhofer, et al., "Crystallization, Crystal Structure Analysis and Atomic Model of the Complex Formed by a Human Fc Fragment and Fragment B of Protein A from Staphylococcus aureus," Hoppe-Seyler's Z. Physiol Chem., 359, pp. 975-985, 1978.
Deisenhofer, "Cyrstallographic Refinement and Atomic Models of a Human Fc Fragment and Its Complex with Fragment B of Protein A from Staphylococcus areus at 2.9- and 2.8-.ANG. Resolution," Biochemistry, vol. 20, No. 9, pp. 2361-2370 (1981).
Fryer et al., "Beyond Hyperacute Rejection, Accelerated Rejection in a Discordant Xenograft Model by Adoptive Transfer of Specific Cell Subsets," Transplantation, vol. 59, No. 2, pp. 171-176 (1995).
Fryer, "Prolongation of Discordant Xenograft Survival by Inhibition of C1Q Deposition," Abstract for 15th Annual Scientific Meeting for The American Society of Transplant Physicians (1996) May 26-29.
Jones, "2010--a pig odyssey," Nature Biotechnology, vol. 14 pp. 698-700 (1996).
Kennedy, "Protection of Porcine Aortic Endothelial Cells from Complement-Mediated Cell Lysis and Activation by Recombinant Human CD59," Transplantation, vol. 57, No. 10, pp. 1494-1501 (1994).
Makowka, et al., "The Use of a Pig Liver Xenograft for Temporary Support of a Patient with Fulminant Hepatic Failure," Transplantation, vol. 59, No. 12, pp. 1654-1659 (1995).
Ryan, "Complement inhibitory therapeutics and xenotransplantation," Nature Medicine, vol. 1, No. 9, pp. 967-968 (1995).
Travis, "The Xeno-Solution, Perils and promise of transplanting animal organs into people," Science News, vol. 148, pp. 298-301 (1995).

Affiliated with

Also associated with

Rating

Synthetic peptide and its uses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Synthetic peptide and its uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic peptide and its uses will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-849053